Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors - Contacts and Locations

Home

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors

This study is ongoing, but not recruiting participants.

Study NCT00003478. Last updated on November 22, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00003478

Locations


United States, North Carolina
	Duke Comprehensive Cancer Center
	Durham, North Carolina, United States, 27710

Sponsors and Collaborators

Duke University

National Cancer Institute (NCI)

Investigators


Study Chair:	Darell D. Bigner, MD, PhD	Duke University